StratifAI builds AI models that turn histology images and clinical data into prognostic insights for oncology.

About

Founded in 2023 and headquartered in Berlin, StratifAI is a pioneer in precision oncology dedicated to making personalized cancer treatment both accessible and scalable. Through its proprietary multimodal AI platform, Polaris™, the company transforms routinely available healthcare data, such as standard H&E histology slides, into high-definition insights into spatial biology. By identifying prognostic and predictive biomarkers that were previously hidden, StratifAI enables clinicians to determine a patient’s risk of recurrence and potential drug response without the need for expensive, time-consuming molecular testing.